Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Jan 18, 2021
Date Accepted: Sep 3, 2021

The final, peer-reviewed published version of this preprint can be found here:

Use of Deep Learning to Predict Acute Kidney Injury After Intravenous Contrast Media Administration: Prediction Model Development Study

Yun D, Cho S, Kim YC, Kim DK, Oh KH, Joo KW, Kim YS, Han SS

Use of Deep Learning to Predict Acute Kidney Injury After Intravenous Contrast Media Administration: Prediction Model Development Study

JMIR Med Inform 2021;9(10):e27177

DOI: 10.2196/27177

PMID: 34596574

PMCID: 8520134

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Use of deep learning to predict acute kidney injury after intravenous contrast media administration

  • Donghwan Yun; 
  • Semin Cho; 
  • Yong Chul Kim; 
  • Dong Ki Kim; 
  • Kook-Hwan Oh; 
  • Kwon Wook Joo; 
  • Yon Su Kim; 
  • Seung Seok Han

ABSTRACT

Background:

Precise prediction of contrast media-induced acute kidney injury (CIAKI) is an important issue because of its relationship with worse outcomes.

Objective:

Herein, we examined whether a deep learning algorithm could predict the risk of intravenous CIAKI better than other machine learning and logistic regression models in patients undergoing computed tomography.

Methods:

A total of 14,185 cases that underwent intravenous contrast media for computed tomography under the preventive and monitoring facility in Seoul National University Hospital were reviewed. CIAKI was defined as an increase in serum creatinine ≥0.3 mg/dl within 2 days and/or ≥50% within 7 days. Using both time-varying and time-invariant features, machine learning models, such as the recurrent neural network (RNN), light gradient boosting machine, extreme boosting machine, random forest, decision tree, support vector machine, κ-nearest neighboring, and logistic regression, were developed using a training set, and their performance was compared using the area under the receiver operating characteristic curve (AUROC) in a test set.

Results:

CIAKI developed in 261 cases (1.8%). The RNN model had the highest AUROC value of 0.755 (0.708–0.802) for predicting CIAKI, which was superior to those obtained from other machine learning models. Although CIAKI was defined as an increase in serum creatinine ≥0.5 mg/dl and/or ≥25% within 3 days, the highest performance was achieved in the RNN model with an AUROC of 0.716 (0.664–0.768). In the feature ranking analysis, albumin level was the most highly contributing factor to RNN performance, followed by time-varying kidney function.

Conclusions:

Application of a deep learning algorithm improves the predictability of intravenous CIAKI after computed tomography, representing a basis for future clinical alarming and preventive systems.


 Citation

Please cite as:

Yun D, Cho S, Kim YC, Kim DK, Oh KH, Joo KW, Kim YS, Han SS

Use of Deep Learning to Predict Acute Kidney Injury After Intravenous Contrast Media Administration: Prediction Model Development Study

JMIR Med Inform 2021;9(10):e27177

DOI: 10.2196/27177

PMID: 34596574

PMCID: 8520134

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.